Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -6.83%1.16B | -10.21%2.8B | -15.90%1.24B | -17.75%3.12B | -32.24%1.48B | -28.24%3.79B | -19.48%2.18B | -37.11%5.28B | -10.89%2.71B | 28.43%8.4B |
| Operating income | -6.83%1.16B | -10.21%2.8B | -15.90%1.24B | -17.75%3.12B | -32.24%1.48B | -28.24%3.79B | -19.48%2.18B | -37.11%5.28B | -10.89%2.71B | 28.43%8.4B |
| Cost of sales | 3.09%-1.01B | 4.75%-2.34B | 11.75%-1.04B | 18.91%-2.46B | 31.04%-1.18B | 23.43%-3.04B | 16.43%-1.71B | 37.08%-3.96B | 15.38%-2.05B | -33.89%-6.3B |
| Operating expenses | 3.09%-1.01B | 4.75%-2.34B | 11.75%-1.04B | 18.91%-2.46B | 31.04%-1.18B | 23.43%-3.04B | 16.43%-1.71B | 37.08%-3.96B | 15.38%-2.05B | -33.89%-6.3B |
| Gross profit | -26.18%148.52M | -30.74%453.73M | -32.36%201.18M | -13.10%655.11M | -36.61%297.45M | -42.74%753.85M | -28.93%469.25M | -37.19%1.32B | 6.68%660.26M | 14.40%2.1B |
| Selling expenses | -4.69%-15.22M | 0.74%-33.26M | 20.53%-14.54M | 20.27%-33.51M | 12.58%-18.29M | 13.11%-42.03M | 15.05%-20.92M | -13.97%-48.37M | -7.21%-24.63M | 2.20%-42.45M |
| Administrative expenses | -105.04%-454.82M | -49.83%-633.51M | -37.13%-221.82M | 58.92%-422.83M | 24.45%-161.76M | -58.19%-1.03B | -6.48%-214.09M | -47.31%-650.67M | 12.79%-201.06M | -4.12%-441.69M |
| Impairment and provision | 9.60%-249.08M | -124.32%-751.62M | -1,400.29%-275.52M | 45.93%-335.07M | 301.51%21.19M | -47.85%-619.68M | 83.93%-10.52M | -497.42%-419.13M | -72.09%-65.43M | -44.57%-70.16M |
| -Other impairment is provision | 9.60%-249.08M | -124.32%-751.62M | -1,400.29%-275.52M | 45.93%-335.07M | 301.51%21.19M | -47.85%-619.68M | 83.93%-10.52M | -497.42%-419.13M | -72.09%-65.43M | -44.57%-70.16M |
| Special items of operating profit | -74.29%5.48M | -132.88%-79.79M | -74.64%21.31M | -80.79%242.65M | 2,015.97%84M | 478.46%1.26B | -68.33%3.97M | 61.22%218.41M | -73.93%12.54M | 10.50%135.48M |
| Operating profit | -95.28%-565.12M | -1,082.05%-1.04B | -230.00%-289.39M | -67.40%106.35M | -2.24%222.6M | -21.72%326.26M | -40.34%227.69M | -75.15%416.8M | 1.66%381.67M | 16.58%1.68B |
| Financing income | -38.98%3.1M | 153.39%11.09M | -80.15%5.07M | -73.97%4.38M | 978.48%25.56M | 53.73%16.81M | -17.34%2.37M | -62.30%10.93M | -87.09%2.87M | -56.24%29M |
| Financing cost | 22.28%-483.25M | -19.50%-1.14B | -20.23%-621.79M | 29.16%-955.61M | 30.44%-517.16M | 12.24%-1.35B | 2.33%-743.51M | -19.88%-1.54B | -31.00%-761.24M | -45.64%-1.28B |
| Special items of earning before tax | -96.10%1.01M | 21.74%36.78M | 7.61%25.91M | 28.25%30.22M | 77.72%24.08M | -69.99%23.56M | 643.22%13.55M | -0.07%78.52M | -117.27%-2.49M | 48.46%78.57M |
| Earning before tax | -18.64%-1.04B | -162.50%-2.14B | -259.38%-880.19M | 17.07%-814.67M | 51.01%-244.92M | 4.71%-982.36M | -31.83%-499.9M | -305.11%-1.03B | -124.39%-379.19M | -25.82%502.62M |
| Tax | 92.72%-3.18M | 84.58%-27.74M | -1,022.95%-43.75M | -2.24%-179.94M | -60.40%-3.9M | -623.61%-175.99M | -115.26%-2.43M | 84.92%-24.32M | 165.83%15.92M | -30.36%-161.31M |
| After-tax profit from continuing operations | -13.37%-1.05B | -117.80%-2.17B | -271.34%-923.94M | 14.14%-994.61M | 50.47%-248.82M | -9.77%-1.16B | -38.28%-502.33M | -409.18%-1.06B | -88.06%-363.28M | -38.37%341.31M |
| Earning after tax | -13.37%-1.05B | -117.80%-2.17B | -271.34%-923.94M | 14.14%-994.61M | 50.47%-248.82M | -9.77%-1.16B | -38.28%-502.33M | -409.18%-1.06B | -88.06%-363.28M | -38.37%341.31M |
| Minority profit | 4.85%-172.02M | -39.25%-426.86M | -219.84%-180.8M | -49.12%-306.54M | 27.01%-56.53M | -23.12%-205.56M | 1.25%-77.45M | -29,086.98%-166.97M | -818.42%-78.43M | -98.39%576K |
| Special items of profit attributable to shareholders | ---- | ---- | ---- | ---- | ---- | -5.31%107.56M | 157.96%69.14M | -3.45%113.59M | -71.45%26.8M | -1.80%117.64M |
| Profit attributable to shareholders | -17.80%-875.43M | -152.79%-1.74B | -286.47%-743.14M | 35.11%-688.07M | 61.08%-192.29M | -5.84%-1.06B | -58.52%-494.02M | -549.08%-1B | -4.60%-311.65M | -43.97%223.1M |
| Basic earnings per share | -17.82%-0.734 | -152.69%-1.458 | -286.96%-0.623 | 35.10%-0.577 | 61.11%-0.161 | -5.83%-0.889 | -58.62%-0.414 | -549.20%-0.84 | -4.40%-0.261 | -44.01%0.187 |
| Diluted earnings per share | -17.82%-0.734 | -152.69%-1.458 | -286.96%-0.623 | 35.10%-0.577 | 61.11%-0.161 | -5.83%-0.889 | -58.62%-0.414 | -549.20%-0.84 | -4.40%-0.261 | -44.01%0.187 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Fruimaz Certified Public Accountants Limited, China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants Limited | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants Limited | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants Limited | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.